The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including […]

The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including […]

The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including […]

The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including […]

The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including […]

The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including […]

The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including […]